WO1997041150A3 - Gene therapy for mitochondrial dna deffects using peptide nucleic acids - Google Patents

Gene therapy for mitochondrial dna deffects using peptide nucleic acids Download PDF

Info

Publication number
WO1997041150A3
WO1997041150A3 PCT/GB1997/001102 GB9701102W WO9741150A3 WO 1997041150 A3 WO1997041150 A3 WO 1997041150A3 GB 9701102 W GB9701102 W GB 9701102W WO 9741150 A3 WO9741150 A3 WO 9741150A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
peptide nucleic
mitochondrial dna
deffects
gene therapy
Prior art date
Application number
PCT/GB1997/001102
Other languages
French (fr)
Other versions
WO1997041150A2 (en
Inventor
Douglas Matthew Turnbull
Robert Neil Lightowlers
Robert William Taylor
Original Assignee
Univ Newcastle
Douglas Matthew Turnbull
Robert Neil Lightowlers
Robert William Taylor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Newcastle, Douglas Matthew Turnbull, Robert Neil Lightowlers, Robert William Taylor filed Critical Univ Newcastle
Publication of WO1997041150A2 publication Critical patent/WO1997041150A2/en
Publication of WO1997041150A3 publication Critical patent/WO1997041150A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0053—Oxidoreductases (1.) acting on a heme group of donors (1.9)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention concerns a method for selectively preventing the replication of mitochondrial DNA using complementary peptide nucleic acids; and the peptide nucleic acids for use in the method. Additionally novel targeting means are described for ensuring the targeting of the peptide nucleic acids into mitochondria.
PCT/GB1997/001102 1996-04-27 1997-04-22 Gene therapy for mitochondrial dna deffects using peptide nucleic acids WO1997041150A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9608803.4A GB9608803D0 (en) 1996-04-27 1996-04-27 Mitochondrial dna defects
GB9608803.4 1996-04-27

Publications (2)

Publication Number Publication Date
WO1997041150A2 WO1997041150A2 (en) 1997-11-06
WO1997041150A3 true WO1997041150A3 (en) 1997-12-04

Family

ID=10792795

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/001102 WO1997041150A2 (en) 1996-04-27 1997-04-22 Gene therapy for mitochondrial dna deffects using peptide nucleic acids

Country Status (2)

Country Link
GB (1) GB9608803D0 (en)
WO (1) WO1997041150A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472209B1 (en) 1997-10-17 2002-10-29 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response
US6723560B2 (en) 1998-10-08 2004-04-20 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response
US6989270B1 (en) 1997-10-17 2006-01-24 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response
EP1574210B1 (en) 1999-02-26 2016-04-06 Novartis Vaccines and Diagnostics, Inc. Microemulsions with adsorbed macromolecules

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020702A1 (en) * 1991-05-24 1992-11-26 Ole Buchardt Peptide nucleic acids
WO1995034665A2 (en) * 1994-06-16 1995-12-21 Peter Seibel Chimerical peptide-nucleic acid fragment, process for producing the same and its use for appropriately introducing nucleic acids into cell organelles and cells
WO1996004000A1 (en) * 1994-08-05 1996-02-15 The Regents Of The University Of California PEPTIDE-BASED NUCLEIC ACID MIMICS (PENAMs)
EP0700928A1 (en) * 1994-08-08 1996-03-13 Bayer Ag Nucleic acid-binding oligomers for therapy and diagnostics

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020702A1 (en) * 1991-05-24 1992-11-26 Ole Buchardt Peptide nucleic acids
WO1995034665A2 (en) * 1994-06-16 1995-12-21 Peter Seibel Chimerical peptide-nucleic acid fragment, process for producing the same and its use for appropriately introducing nucleic acids into cell organelles and cells
WO1996004000A1 (en) * 1994-08-05 1996-02-15 The Regents Of The University Of California PEPTIDE-BASED NUCLEIC ACID MIMICS (PENAMs)
EP0700928A1 (en) * 1994-08-08 1996-03-13 Bayer Ag Nucleic acid-binding oligomers for therapy and diagnostics

Also Published As

Publication number Publication date
WO1997041150A2 (en) 1997-11-06
GB9608803D0 (en) 1996-07-03

Similar Documents

Publication Publication Date Title
ZA963434B (en) Gene therapy using replication competent targeted adenoviral vectors.
AU1082199A (en) Apparatus and methods for sequencing nucleic acids in microfluidic systems
HUP9801216A3 (en) Dna molecules, preparation thereof and use thereof in gene therapy
AU4049589A (en) Rna and dna amplification techniques
AU1606897A (en) Thymidine kinase variants, corresponding nucleic acid sequences and their use in gene therapy
AU5440198A (en) Method for the identification of peptides that recognize specific dna sequences
AU6277799A (en) Il-17 homolog nucleic acids, polypeptides, vectors, host cells, methods and usesthereof
EP0828003A3 (en) Human serine protease
AU2002218269A1 (en) Proteins and dna sequences underlying these proteins used for treating inflammations
EP1012603A4 (en) Functional fragments of hiv-1 vpr protein and methods of using the same
ZA9710163B (en) Novel carboxylesterase nucleic acid molecules, proteins and uses thereof.
NO981322L (en) Pharmaceutical surface preparations for use in nucleic acid transfection and their use
AU3866197A (en) Novel DNA and process for preparing protein using the DNA
AU1382099A (en) Human phospholipase a2 protein and dna encoding it
AU3911897A (en) Phospholipase d and dna sequences
ZA979295B (en) Methods and compositions for delivery and expression of interferon-Ó nucleic acids.
AU7147898A (en) (dirofilaria) and (brugia) ankyrin proteins, nucleic acid molecules, and uses thereof
WO1997041150A3 (en) Gene therapy for mitochondrial dna deffects using peptide nucleic acids
AU7072896A (en) Dna encoding medicinal proteins
DE69732506D1 (en) Prenyl diphosphate synthetase genes
AU3670395A (en) Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
WO1998044134A3 (en) Bacterial plasmids
AU5178698A (en) Novel serine protease inhibitor nucleic acid molecules, proteins and uses hereof
AU1525499A (en) Ikap proteins, nucleic acids and methods
AU6550598A (en) Antithrombin protein and dna sequences

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97538656

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase